Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06982755

Acupuncture Versus Compound Diclofenac Sodium for Pain Relief in Non-Traumatic Acute Abdominal

Effect of Acupuncture on Early Analgesia of Non-traumatic Acute Abdomen is Discussed Based on the Experience of Sanli Acupoint for Du-fu Diseases :A Prospective Randomized Controlled pRCT Study

Status
Not Yet Recruiting
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
176 (estimated)
Sponsor
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine · Academic / Other
Sex
All
Age
16 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The investigators designed this clinical study to evaluate the efficacy and safety of semi-standardized acupuncture and moxibustion combined with compound diclofenac sodium injection in the emergency department (ED) compared with acupuncture or compound diclofenac sodium injection alone.

Detailed description

This study is a prospective, parallel-controlled, open-label randomized controlled trial (RCT). The Numeric Rating Scale (NRS) was used to assess pain intensity. The primary outcome measure was the difference in pain response rates between the combined intervention group, the acupuncture-only group, and the diclofenac sodium combination group at 10 minutes post-treatment compared to baseline. Secondary outcomes included treatment response rates, NRS scores, pain recurrence rates, rescue medication rates, and adverse events at each observation time point across the three groups. Additionally, a placebo group was included to exploratorily assess the placebo effect of the intervention.

Conditions

Interventions

TypeNameDescription
PROCEDUREacupunctureacupuncture at Zusanli (ST36); sample size: 44
DRUGcompound diclofenac sodiumintramuscular injection of compound diclofenac sodium injection; sample size: 44
COMBINATION_PRODUCTacupuncture combined with compound diclofenac sodiumacupuncture at Zusanli (ST36) and intramuscular injection of compound diclofenac sodium injection; sample size: 44
COMBINATION_PRODUCTplacebosuperficial acupuncture at Zusanli (ST36) and intramuscular injection of normal saline; sample size: 44

Timeline

Start date
2025-06-01
Primary completion
2025-12-31
Completion
2026-12-31
First posted
2025-05-21
Last updated
2025-05-21

Source: ClinicalTrials.gov record NCT06982755. Inclusion in this directory is not an endorsement.